NCT06253858

Ultrasound (US) Guided External Ventricular Catheter Placement

Milton S. Hershey Medical Center·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Hydrocephalus
Drug/Device/Intervention
Catheter Placement with Solopass System
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Milton S. Hershey Medical Center
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Mar 01, 2025
Enrollment
10 participants
Primary outcome

Average number of passes needed to place the catheter in each subject.

Summary

To assess the accuracy the SOLOPASS® System US based in the placement of external ventricular
 drain into the cranial cavity. This study will aim at evaluating the proposed efficacy of the
 device in targeting the brain ventricles and decrease multiple brain passes, incorrect
 deployment and malfunctioning of the drain.

ICD-10 classifications
HydrocephalusHydrocephalus, unspecifiedOther hydrocephalusCongenital hydrocephalusObstructive hydrocephalus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06253858
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06253858 through Pure Global AI's free database. This phase not specified trial is sponsored by Milton S. Hershey Medical Center and is currently Not yet recruiting. The study focuses on Hydrocephalus. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.